Navigation Links
Comparative genomics reveals molecular evolution of Q fever pathogen
Date:2/2/2009

Blacksburg, Va. Scientists from the National Institute of Allergy and Infectious Diseases, Texas A&M Health Center, and the Virginia Bioinformatics Institute at Virginia Tech have uncovered genetic clues about why some strains of the pathogen Coxiella burnetii are more virulent than others.

The researchers compared the sequences of four different strains of C. burnetii, an intracellular bacterium that can cause acute and chronic Q fever in humans, to build up a comprehensive picture of the genetic architecture and content of the different genomes. The scientists examined C. burnetii strains of differing virulence to unveil clues on the genetic features associated with pathogenicity.

Q fever is considered one of the most infectious diseases in the world since inhalation of a single bacterium alone is sufficient to kick-start infection. Infection in humans typically results from contact with infected animals such as cattle, goats, and sheep. The C. burnetii bacterium targets macrophages white blood cells in the body that usually provide protection against invading pathogens. The pathogen has the remarkable ability to replicate in a lysosome-like vacuole of macrophages, an extremely harsh intracellular environment that usually protects the body from infection by breaking down invading pathogens. The chronic form of Q fever in humans is rare but can lead to heart infections that are usually deadly if untreated.

Dr. Robert Heinzen, head of the Coxiella Pathogenesis Section at the National Institute of Allergy and Infectious Disease, remarked: "Our results suggest that mobile genetic elements have played a major role in the evolution and function of the C. burnetii genome. Recombination between insertion sequence elements or jumping genes appears to have brought about large-scale generation of non-functional genes, a change that may be associated with a more pathogenic lifestyle."

In the study, the researchers sequenced the genomes of three strains of the bacteria and made a four-way comparison of C. burnetii genomic sequences. Strain virulence was associated with a smaller genome. The loss of genes was due in part to the formation of pseudogenes, evolutionary remnants of earlier genes that no longer code for functional proteins.

Kelly Williams, research investigator at VBI, commented: "A principle of our and many modern studies was first enunciated in the title of a 1965 paper by Emile Zuckerkandl and Linus Pauling, 'Molecules as documents of evolutionary history'. Genomes are the ultimate molecular documents, filled with stories that fascinate and instruct, and we can now speed-read them."

VBI Executive and Scientific Director Bruno Sobral, a co-author on the paper, remarked: "2009 is the 200th anniversary of the birth of Darwin. That's a very suitable time to step back and think about how new technologies are giving us ever more powerful ways to investigate the history and mechanism of evolution. We hope the work in the current study serves as a resource for both the Coxiella and wider infectious disease research communities interested in the evolution of pathogen virulence."

Dr. Heinzen concluded: "The results of this study provide a solid foundation upon which we can test a number of hypotheses related to C. burnetii gene function and virulence. This information will prove invaluable as we proceed to dissect, at a molecular level, events associated with Q fever pathogenesis"


'/>"/>

Contact: Barry Whyte
whyte@vbi.vt.edu
540-231-1767
Virginia Tech
Source:Eurekalert

Related biology news :

1. Mixing genomics and geography yields insights into life and environment
2. Human genomics in China
3. Nutrigenomics -- developing personalized diets for disease prevention
4. New gene variants present opportunities in nutrigenomics
5. Computation and genomics data drive bacterial research into new golden age
6. Genetic Engineering & Biotechnology News reports on the trend toward predictive toxicogenomics
7. Complete Genomics launches, becomes worlds first large-scale human genome sequencing company
8. Broad Institute awarded major grant to bolster epigenomics research
9. Review article provides tools for the Rosaceae genomics community
10. Genomics of large marine animals showcased in the biological bulletin
11. Human Genomics and Proteomics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... , Nov. 29, 2016   ... identification and object recognition technologies, today released ... for fingerprint recognition solutions that run on ... fingerprint template using less than 128KB of ... compact devices that have limited on-board resources, ...
(Date:11/28/2016)... 2016 "The biometric system ... The biometric system market is in the growth ... near future. The biometric system market is expected to ... a CAGR of 16.79% between 2016 and 2022. Government ... technology in smartphones, rising use of biometric technology in ...
(Date:11/22/2016)... 2016 According to the new market research report ... Vein, Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), ... market is expected to grow from USD 10.74 Billion in 2015 to ... 2016 and 2022. Continue Reading ... ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  Anaconda BioMed S.L., a pre-clinical ... the next generation neuro-thrombectomy system for the treatment of ... G. Jovin, MD to join its Scientific Advisory Board ... strategic network of scientific and clinical experts to Anaconda ... the ANCD BRAIN ® to its clinical phase. ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion medium. This ... products engineered to radically streamline culture processes, minimize processing time, significantly decrease ...
(Date:12/8/2016)... Ames, Iowa (PRWEB) , ... December 08, 2016 , ... ... of asynchronous approvals for biotech crops. The authors focus on the economic effects in ... the global approval of new biotech crops and the resultant risk of low level ...
(Date:12/8/2016)... -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), ... products to treat rare diseases where there is an ... hosting an Investor Webcast Event Friday, December 16, 2016, ... defense regulators (IDRs) as a new drug class, as ... recently announced and published Phase 2 clinical data for ...
Breaking Biology Technology: